Voya Investment Management LLC Has $27.42 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Voya Investment Management LLC lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 124.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 350,737 shares of the company's stock after purchasing an additional 194,290 shares during the period. Voya Investment Management LLC owned approximately 0.08% of GE HealthCare Technologies worth $27,421,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Morse Asset Management Inc acquired a new position in GE HealthCare Technologies in the third quarter valued at approximately $613,000. Diamant Asset Management Inc. increased its stake in shares of GE HealthCare Technologies by 4.2% in the 3rd quarter. Diamant Asset Management Inc. now owns 10,257 shares of the company's stock valued at $963,000 after acquiring an additional 410 shares during the last quarter. World Investment Advisors LLC raised its position in shares of GE HealthCare Technologies by 44.5% in the 3rd quarter. World Investment Advisors LLC now owns 4,716 shares of the company's stock valued at $443,000 after acquiring an additional 1,453 shares during the period. Wilmington Savings Fund Society FSB boosted its stake in GE HealthCare Technologies by 150.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 11,278 shares of the company's stock worth $1,058,000 after acquiring an additional 6,770 shares during the last quarter. Finally, Tidal Investments LLC increased its stake in GE HealthCare Technologies by 32.5% in the third quarter. Tidal Investments LLC now owns 23,715 shares of the company's stock valued at $2,226,000 after purchasing an additional 5,819 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently commented on GEHC. BTIG Research set a $95.00 price objective on shares of GE HealthCare Technologies and gave the company a "buy" rating in a research report on Monday, April 14th. Citigroup lowered their price objective on shares of GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating for the company in a research report on Wednesday. The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and increased their target price for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. Finally, Piper Sandler reduced their price target on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $94.50.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC traded up $2.24 on Wednesday, hitting $70.33. The company's stock had a trading volume of 12,749,274 shares, compared to its average volume of 3,310,086. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The stock has a fifty day moving average of $75.62 and a two-hundred day moving average of $81.81. The firm has a market capitalization of $32.20 billion, a P/E ratio of 16.24, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.10. The firm had revenue of $4.78 billion during the quarter, compared to analysts' expectations of $4.66 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.90 earnings per share. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.20%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.